Related Experiment Video
Updated: Aug 12, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
RBM15 silencing promotes ferroptosis by regulating the TGF-β/Smad2 pathway in lung cancer
Jing Feng1, Yaling Li1, Fen He1
1Department of Thoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, China.
Objective:
We assessed the function and mechanism of RNA binding motif protein 15 (RBM15) silencing in lung cancer development.
Methods:
The effects of RBM15 knockdown on A549 and H1299 cells were evaluated by MTT, EdU, wound healing, and transwell assay. We then detected the functions of RBM15 silencing on lipid peroxidation, labile iron pool (LIP), ferrous iron (Fe2+ ), and ferroptosis-related genes. RNA sequencing was performed after RBM15 knockout in lung cancer cells, followed by differentially expressed genes (DEGs), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed. Finally, the expression of RBM15 and pathway-related genes was determined by western blot.
Results:
RBM15 was highly expressed in lung cancer cells. RBM15 silencing reduced the viability, inhibited cell proliferation, invasion, and migration, and suppressed tumor growth in the xenograft mouse model. Knockout of RBM15 regulated ferroptosis-related gene expression. LIP, Fe2+ , and lipid peroxidation were distinctly increased by the knockout of RBM15. RNA-seq sequencing revealed that there are 367 up-regulated and 368 down-regulated DEGs, which were enriched in molecular functions, biological processes, and cellular components. RBM15 silencing reduced the expression of TGF-β/Smad2, and TGF-β activator (SRI-011381) reversed the inhibitory effect of RBM15 silencing on tumor cell growth.
Conclusion:
We demonstrated that RBM15 silencing promoted ferroptosis in lung cancer cells by TGF-β/Smad2 pathway, thereby inhibiting lung cancer cell growth, which may provide new light for lung cancer treatment.
Insights
Silencing RNA binding motif protein 15 (RBM15) in lung cancer cells promotes ferroptosis and inhibits tumor growth. This occurs via the TGF-β/Smad2 pathway, offering potential new therapeutic strategies for lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- RNA binding motif protein 15 (RBM15) is implicated in various cancers.
- The role of RBM15 in lung cancer development and its underlying mechanisms require further elucidation.
- Understanding RBM15's function is crucial for developing targeted lung cancer therapies.
Purpose of the Study:
- To investigate the function and mechanism of RNA binding motif protein 15 (RBM15) silencing in lung cancer.
- To determine the impact of RBM15 knockdown on lung cancer cell proliferation, invasion, and migration.
- To explore the role of RBM15 in regulating ferroptosis and associated signaling pathways in lung cancer.
Main Methods:
- Cell viability, proliferation, invasion, and migration assays (MTT, EdU, wound healing, transwell) were performed after RBM15 knockdown in A549 and H1299 lung cancer cells.
- Analysis of lipid peroxidation, labile iron pool (LIP), ferrous iron (Fe2+), and ferroptosis-related gene expression.
- RNA sequencing (RNA-seq) followed by differential gene expression (DEG), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
- Western blot to assess RBM15 and pathway-related gene expression.
Main Results:
- RBM15 is highly expressed in lung cancer cells and its silencing significantly reduced cell viability, proliferation, invasion, and migration.
- RBM15 silencing increased labile iron pool (LIP), ferrous iron (Fe2+), and lipid peroxidation, indicating promotion of ferroptosis.
- RNA-seq identified 367 upregulated and 368 downregulated DEGs, enriched in key cellular functions and pathways.
- RBM15 silencing decreased TGF-β/Smad2 pathway expression, and TGF-β activator reversed the inhibitory effects.
Conclusions:
- RBM15 silencing promotes ferroptosis in lung cancer cells through the TGF-β/Smad2 pathway.
- Inhibition of RBM15 suppresses lung cancer cell growth and tumor progression.
- Targeting RBM15 offers a promising therapeutic strategy for lung cancer treatment.
Related Concept Videos
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs
Abnormal Proliferation

